155 related articles for article (PubMed ID: 28982830)
1. Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study.
Rapport F; Hogden A; Gurney H; Gillatt D; Bierbaum M; Shih P; Churruca K
BMJ Open; 2017 Oct; 7(10):e017372. PubMed ID: 28982830
[TBL] [Abstract][Full Text] [Related]
2. Ethnographic investigation of patient-provider communication among African American men newly diagnosed with prostate cancer: a study protocol.
Palmer NR; Shim JK; Kaplan CP; Schillinger D; Blaschko SD; Breyer BN; Pasick RJ
BMJ Open; 2020 Aug; 10(8):e035032. PubMed ID: 32759241
[TBL] [Abstract][Full Text] [Related]
3. Appraising risk in active surveillance of localized prostate cancer.
Hogden A; Churruca K; Rapport F; Gillatt D
Health Expect; 2019 Oct; 22(5):1028-1039. PubMed ID: 31095822
[TBL] [Abstract][Full Text] [Related]
4. A Narrative Overview of Active Surveillance for Clinically Localised Prostate Cancer.
Bates AS; Kostakopoulos N; Ayers J; Jameson M; Todd J; Lukha R; Cymes W; Chasapi D; Brown N; Bhattacharya Y; Paterson C; Lam TBL
Semin Oncol Nurs; 2020 Aug; 36(4):151045. PubMed ID: 32703714
[TBL] [Abstract][Full Text] [Related]
5. Fit for purpose? OrganisationaL prOdUctivity and woRkforce wellbeIng in workSpaces in Hospital (FLOURISH): a multimethod qualitative study protocol.
Rapport F; Auton E; Cartmill J; Braithwaite J; Shih P; Hogden A; Clay-Williams R
BMJ Open; 2019 Apr; 9(4):e027636. PubMed ID: 31005940
[TBL] [Abstract][Full Text] [Related]
6. Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial.
Wade J; Holding PN; Bonnington S; Rooshenas L; Lane JA; Salter CE; Tilling K; Speakman MJ; Brewster SF; Evans S; Neal DE; Hamdy FC; Donovan JL;
BMJ Open; 2015 Sep; 5(9):e008953. PubMed ID: 26384727
[TBL] [Abstract][Full Text] [Related]
7. Factors that influence clinicians' decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study.
Lowenstein LM; Choi NJ; Hoffman KE; Volk RJ; Loeb S
BMJ Open; 2021 Nov; 11(11):e048347. PubMed ID: 34772748
[TBL] [Abstract][Full Text] [Related]
8. Qualitative, multimethod study of behavioural and attitudinal responses to cochlear implantation from the patient and healthcare professional perspective in Australia and the UK: study protocol.
Rapport F; Bierbaum M; McMahon C; Boisvert I; Lau A; Braithwaite J; Hughes S
BMJ Open; 2018 May; 8(5):e019623. PubMed ID: 29844099
[TBL] [Abstract][Full Text] [Related]
9. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
10. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
Eur Urol; 2017 Oct; 72(4):534-541. PubMed ID: 27816297
[TBL] [Abstract][Full Text] [Related]
11. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
[TBL] [Abstract][Full Text] [Related]
12. Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians.
Pattenden TA; Thangasamy IA; Ong WL; Samaranayke D; Morton A; Murphy DG; Evans S; Millar J; Chalasani V; Rashid P; Winter M; Vela I; Pryor D; Mark S; Loeb S; Lawrentschuk N; Pritchard E
BJU Int; 2024 Feb; 133 Suppl 3():48-56. PubMed ID: 37696615
[TBL] [Abstract][Full Text] [Related]
13. Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study.
Chambers SK; Hyde MK; Laurie K; Legg M; Frydenberg M; Davis ID; Lowe A; Dunn J
BMJ Open; 2018 Feb; 8(2):e019917. PubMed ID: 29455168
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
[TBL] [Abstract][Full Text] [Related]
15. Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
[TBL] [Abstract][Full Text] [Related]
16. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
17. Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.
Radhakrishnan A; Subramanian L; Rankin AJ; Fetters MD; Wittmann DA; Ginsburg KB; Hawley ST; Skolarus TA
Ann Fam Med; 2024; 22(1):5-11. PubMed ID: 38253492
[TBL] [Abstract][Full Text] [Related]
18. Research protocol for the Picture Talk Project: a qualitative study on research and consent with remote Australian Aboriginal communities.
Fitzpatrick EFM; Carter M; Oscar J; Lawford T; Martiniuk ALC; D'Antoine HA; Elliott EJ
BMJ Open; 2017 Dec; 7(12):e018452. PubMed ID: 29288181
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
[TBL] [Abstract][Full Text] [Related]
20. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
